Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2000-11-13
pubmed:abstractText
In this study, we investigated the involvement of the interaction between sigma receptors and the nitric oxide/cyclic GMP pathway in short term memory in mice, assessed through spontaneous alternation behavior in a Y-maze. N(G)-Nitro-L-arginine methyl ester and 7-nitro indazole, both nitric oxide synthase inhibitors, impaired the spontaneous alternation behavior. These impairments were attenuated by (+) SKF 10,047 and (+) pentazocine, sigma(1) receptor agonists. Further, the sigma(1) receptor antagonist, NE-100, reversed the improvements made by sigma receptor agonists. Cyclic GMP levels and nitric oxide synthase activity in the hippocampus were reduced by treatment with N(G)-nitro-L-arginine methyl ester. The suppressive effects of N(G)-nitro-L-arginine methyl ester on the cyclic GMP levels were reversed by co-treatment with (+) SKF 10,047, but the decline in nitric oxide synthase activity was not. These results suggest that the nitric oxide/cyclic GMP pathway in the hippocampus is responsible for spontaneous alternation behavior in a Y-maze. Further, the ameliorating effects of (+) SKF 10,047 on the impairment of spontaneous alternation behavior may be mediated through activation of guanylate cyclase, but not nitric oxide synthase in the hippocampus of mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1,3-ditolylguanidine, http://linkedlifedata.com/resource/pubmed/chemical/7-nitroindazole, http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Anxiety Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Guanidines, http://linkedlifedata.com/resource/pubmed/chemical/Indazoles, http://linkedlifedata.com/resource/pubmed/chemical/Methylene Blue, http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III, http://linkedlifedata.com/resource/pubmed/chemical/Nos3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Pentazocine, http://linkedlifedata.com/resource/pubmed/chemical/Phenazocine, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, sigma, http://linkedlifedata.com/resource/pubmed/chemical/SK&F 10047, http://linkedlifedata.com/resource/pubmed/chemical/alpha-(4-fluorophenyl)-4-(5-fluoro-2...
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0028-3908
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2391-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10974323-Analgesics, Opioid, pubmed-meshheading:10974323-Animals, pubmed-meshheading:10974323-Anti-Anxiety Agents, pubmed-meshheading:10974323-Antipsychotic Agents, pubmed-meshheading:10974323-Behavior, Animal, pubmed-meshheading:10974323-Brain Chemistry, pubmed-meshheading:10974323-Cyclic GMP, pubmed-meshheading:10974323-Enzyme Inhibitors, pubmed-meshheading:10974323-Guanidines, pubmed-meshheading:10974323-Indazoles, pubmed-meshheading:10974323-Male, pubmed-meshheading:10974323-Methylene Blue, pubmed-meshheading:10974323-Mice, pubmed-meshheading:10974323-NG-Nitroarginine Methyl Ester, pubmed-meshheading:10974323-Nitric Oxide Synthase, pubmed-meshheading:10974323-Nitric Oxide Synthase Type II, pubmed-meshheading:10974323-Nitric Oxide Synthase Type III, pubmed-meshheading:10974323-Pentazocine, pubmed-meshheading:10974323-Phenazocine, pubmed-meshheading:10974323-Pyrimidines, pubmed-meshheading:10974323-Receptors, sigma
pubmed:year
2000
pubmed:articleTitle
Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice.
pubmed:affiliation
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, 466-8560, Nagoya, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't